Nektar Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
NKTR Key Statistics
Stock Snapshot
Nektar Therapeutics(NKTR) stock is priced at $72.22, giving the company a market capitalization of 2.05B. It carries a P/E multiple of -7.16.
As of 2026-03-16, Nektar Therapeutics(NKTR) stock has fluctuated between $70.00 and $77.00. The current price stands at $72.22, placing the stock +3.2% above today's low and -6.2% off the high.
Nektar Therapeutics(NKTR) shares are trading with a volume of 1.36M, against a daily average of 984.32K.
During the past year, Nektar Therapeutics(NKTR) stock moved between $6.48 at its lowest and $77.00 at its peak.
During the past year, Nektar Therapeutics(NKTR) stock moved between $6.48 at its lowest and $77.00 at its peak.
NKTR News
Earnings Call Insights Nektar outlines $400M–$460M year-end 2026 cash target as REZPEG enters Phase III in atopic dermatitis Mar. 13, 2026 3:22 AM ET Nektar The...
Reports Q4 revenue $21.8M vs. $29.2M last year. “2025 was a pivotal year for Nektar (NKTR) as we saw successful and transformative Phase 2 data readouts for rez...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.